The United Kingdom announced its plan to use its Presidency of the G8 – the international body comprised of the world’s eight wealthiest Western countries – to spearhead a new collaborative approach to address Alzheimer’s and dementia by advancing dementia research.
A G8 dementia summit will be held in London in September, bringing together health and science ministers with medical and pharmaceutical experts. British Prime Minister David Cameron said he hopes the summit will “secure more coordination and collaboration on dementia globally.”
Although most countries in the G8 have their own targeted plans for ending Alzheimer’s disease and dementia, experts believe a more global approach could lead to significant scientific breakthroughs if countries partner together and share information, research and expertise. The UK also sees a tremendous opportunity to engage pharmaceutical companies into the G8 partnership.
George Vradenburg, chairman of USAgainstAlzheimer’s, applauded the British announcement, saying he hoped it would “turn the United States’ goal to stop Alzheimer’s by 2025 into a global commitment.”
Suggested Articles:
